Agios Pharmaceuticals, Inc. (AGIO)

NASDAQ: AGIO · IEX Real-Time Price · USD

46.61

-1.07 (-2.24%)

At close: Jul 19, 2024, 4:00 PM

45.68

-0.93 (-2.00%)

Pre-market: Jul 22, 2024, 6:18 AM EDT

Agios Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018 - 2011
Revenue	29.4	26.82	14.24	0	0	0	Upgrade
Revenue Growth (YoY)	54.61%	88.36%	-	-	-	-	Upgrade
Cost of Revenue	2.95	2.88	1.7	0	0	0	Upgrade
Gross Profit	26.45	23.94	12.54	0	0	0	Upgrade
Selling, General & Admin	122.55	119.9	121.67	121.45	115.11	102.01	Upgrade
Research & Development	296.85	295.53	279.91	256.97	220.81	214.26	Upgrade
Other Operating Expenses	0	0	-137.7	-6.64	0	0	Upgrade
Operating Expenses	419.4	415.43	263.88	371.78	335.92	316.27	Upgrade
Operating Income	-392.95	-391.49	-251.34	-371.78	-335.92	-316.27	Upgrade
Other Expense / Income	-40.33	-39.4	-19.54	-1,976.49	-8.55	95.2	Upgrade
Pretax Income	-352.62	-352.09	-231.8	1,605	-327.37	-411.47	Upgrade
Net Income	-352.62	-352.09	-231.8	1,605	-327.37	-411.47	Upgrade
Shares Outstanding (Basic)	56	56	55	60	69	60	Upgrade
Shares Outstanding (Diluted)	56	56	55	60	69	60	Upgrade
Shares Change	2.02%	1.57%	-9.36%	-12.39%	15.01%	4.49%	Upgrade
EPS (Basic)	-6.32	-6.33	-4.23	26.55	-4.74	-6.86	Upgrade
EPS (Diluted)	-6.32	-6.33	-4.23	26.55	-4.74	-6.86	Upgrade
Free Cash Flow	-300.27	-295.74	-313.4	-413.06	-258.05	-248.18	Upgrade
Free Cash Flow Per Share	-5.33	-5.31	-5.72	-6.83	-3.74	-4.14	Upgrade
Gross Margin	89.95%	89.26%	88.03%	-	-	-	Upgrade
Operating Margin	-1336.41%	-1459.52%	-1765.05%	-	-	-	Upgrade
Profit Margin	-1199.26%	-1312.63%	-1627.82%	-	-	-	Upgrade
Free Cash Flow Margin	-1021.23%	-1102.55%	-2200.81%	-	-	-	Upgrade
EBITDA	-335.52	-334.75	-213.24	1,623	-308.6	-394.85	Upgrade
EBITDA Margin	-1141.12%	-1247.98%	-1497.49%	-	-	-	Upgrade
Depreciation & Amortization	17.1	17.34	18.56	18.78	18.77	16.62	Upgrade
EBIT	-352.62	-352.09	-231.8	1,605	-327.37	-411.47	Upgrade
EBIT Margin	-1199.26%	-1312.63%	-1627.82%	-	-	-	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).